Walgreens scrapped its deal to buy Rite Aid outright last year
after failing to win antitrust approval, and said it would
instead buy some of the smaller rival's U.S. stores.
Net income attributable to Walgreens rose 15.5 percent to $1.34
billion, or $1.35 per share, in the third quarter ended May 31.
Excluding items, the company earned $1.53 per share, beating
analysts' expectations of $1.48 per share, according to Thomson
Reuters I/B/E/S.
The company also said it had increased its quarterly dividend by
10 percent to 44 cents per share.
Sales at Walgreens' U.S. pharmacies rose 19.3 percent in the
quarter, helped by higher prescription volumes from the Rite Aid
stores.
(Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
 |
|